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Previous  papers  from  this  and  other  laboratories 
have dealt with the increase  of drug-metabolizing 
activities of liver microsomes by administration  of 
certain  drugs  and  with the metabolic events asso- 
ciated  with  this  increase  (1).  Heretofore,  in  this 
laboratory  the  greatest  amount  of  attention  has 
been given to drug hydroxylation,  although  this is 
only one of a  number  of detoxicating systems that 
can be stimulated  by the administration  of drugs. 
In the present  paper  we describe  studies with an- 
other detoxicating system which can be stimulated 
by drug administration,  namely the glucuronylat- 
ing system. We also describe studies on other met- 
abolic  events  occurring  in  association  with  drug 
administration,  namely  increases  in  the  activities 
of mitochondrial oxidative enzymes. 
The glucuronylating pathway is one of the most 
important  routes  for  drug  detoxication.  A  great 
many  drugs  and  foreign products,  as well as nat- 
ural  products,  are excreted in  the urine as glucu- 
ronides,  by  direct  esterificadon  or  after  prior 
hydroxylation.  The  glucuronylation  pathway  has 
been well defined and is given in outline in Fig.  1. 
The first enzyme involved, UDPG  1 dehydrogenase, 
is a  supernatant  enzyme.  It has  been  purified  by 
Strominger  et al.  (2).  The  second  enzyme,  glucu- 
1Abbreviations  employed  in  this  paper:  UDPG, 
Uridine diphosphoglucose; UDPGA, Uridine diphos- 
phoglucuronic acid; NAD  +, nicotinamide adenine di- 
nueleotide; NADP  +,  nicotinamide  adenine dinucleo- 
tide  phosphate;  ADP,  Adenosine  diphosphate ; 
DCPIP,  2,6-dichlorophenolindophenol. 
ronyl  transferase,  is  a  microsomal  enzyme  which 
has  been  studied  extensively  by  Isselbacher  and 
his associates (3). 
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FlOrdRE  1  Metabolic  pathway  of  glucuronylation. 
The  results  reported  here  with  phenobarbital 
administration,  like those obtained by other work- 
ers using a  variety  of drugs  (see  reference 4  for  a 
brief review), show that both UDPG dehydrogenase 
and  glucuronyl  transferase  activities are enhanced 
by  administration  of the  drug.  This  is  in  accord 
with  the  work  of Rammer  (5)  who  showed  that 
administration  of phenobarbital  increases  the me- 
tabolism  of  sulfadimethoxin  via  the  glucuronic 
acid pathway,  as judged by urinary output of con- 
jugated  metabolites.  The  time  course  of  the  re- 
sponse  of the  glucuronyl  transferase  activity is  of 
interest in  that  it  seems  to  be  characterized  by  a 
lag period prior  to the increase.  The increment of 
mitochondrial  oxidative activities also follows  this 
pattern  rather  than  the more rapid  enhancement 
exhibited by the oxidative demethylation  system. 
In  all  experiments  male  Sprague-Dawley  rats 
528  B  R  i  B  F  N  O  T  E  s (200-300  g)  were  used.  The  animals  were  fasted 
overnight prior to the morning of the experiment. 
The experimental  animals were given daily injec- 
tions  of sodium  phenobarbital,  80  mg  per  kg  of 
body weight, intraperitoneally. 
Preparation of liver mitochondria was according 
to the procedure of Ernster and L6w (6). 
Liver  microsomes  were  prepared  as  follows. 
Tissue  was  homogenized  in  5  volumes of 0.15  M 
KC1.  The  homogenate  was  centrifuged  at  10,000 
g  for  10 min  and  the  pellets were discarded.  The 
supernatant  was  then  centrifuged at  105,000 g  for 
1  hr,  and  the  microsomal  pellets  thus  obtained 
were washed two times in the same volume of 0.15 
r~ KCI prior to suspension  in the same medium at 
a  concentration  of  5-10  mg  microsomal  protein 
per ml.  These suspensions  were used to  assay  glu- 
curonyl  transferase  and  oxidative  demethylating 
activities. The supernatant  from the initial  105,000 
g  centrifugation  was  saved  and  used  to  assay 
UDPG dehydrogenase  and  DT diaphorase  activi- 
ties. 
UDPG dehydrogenase was determined from the 
rate  of NAD  +  reduction,  measured  spectrophoto- 
metrically at 340 mu.  The method  was  essentially 
the same as that of Strominger et al.  (2).  Cuvettes 
contained,  in  addition  to  enzyme,  0.6  /~moles  of 
UDPG and  3  #moles of NAD  +  in  a  total  volume 
of 3  ml  of 0.1  ra  glycine  buffer,  pH  8.7.  UDPG 
was omitted from control cuvettes.  Activities were 
calculated  by  subtracting  values of controls  from 
experimental values. 
Glucuronyl  transferase  was  assayed  according 
to the method of Hollmann  and Touster  (7)  using 
p-nitrophenol as substrate,  except that incubations 
were terminated  at 5 min. 
DT diaphorase  was  determined  by  the method 
of Ernster et al.  (8) using both NAD  + and NADP  + 
as substrates. 
Oxidative  demethylation  was  measured  as de- 
scribed  previously (9),  using  aminopyrine  as  sub- 
strate. 
The  rates  of oxygen  consumption  by  rat  liver 
mitochondria  using  succinate,  pyruvate-malate, 
and  alpha  glycerophosphate  as  substrates  in  the 
presence  of  phosphate  and  phosphate  acceptor 
were measured  with a  Clark oxygen electrode. To 
mitochondria  (4  mg  mitochondrial  protein)  in  a 
total volume of 4 ml of Tris-KCl-phosphate buffer, 
pH  7.5,  were  added  successively  20  #l  of  1  M 
MgSO,,  10 #1 of 1 M substrate,  and  10 #1 of 60 rnM 
ADP.  Buffer  concentrations  were:  Tris-HCl,  50 
mM;  KC1,  100  mM;  phosphate,  10  mM.  All deter- 
minations were carried out at 30°C. 
Protein was measured  by  the method  of Lowry 
et al.  (10). 
Results  obtained  with  the  glucuronylating  en- 
zymes,  DT  diaphorase  and  oxidative  demethyla- 
don are shown in Fig. 2.  Daily injections of 80 mg 
phenobarbital  per  kg  of body  weight  to  rats  re- 
sulted in an almost twofold increase in the activities 
of glucuronylating  enzymes.  The  response  of the 
UDPG dehydrogenase, however, was considerably 
faster  than  the  response  of the  glucuronyl  trans- 
ferase which showed no obvious increase until the 
third  day  of drug  administration.  Oxidative  de- 
methylation,  as  observed  previously  (1),  gave an 
immediate response,  whereas there was no change 
in the level of DT diaphorase activity. 
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FIGURE ~  Activities  of  gluem'ony[  trausferase (©), 
UDPG  dehydrogenase (D),  DT  diaphorase, using 
NAD  (×)  and NADP  (A)  as hydrogen donors, and 
oxidative demethylation (Q), all  expressed  as per cent 
of  control  values.  Control  values  were  as  follows. 
Glucuronyl  transferase:  0.678  m/zmoles  p-nitrophenol 
conjugated/min/mg  protein;  UDPG  dehydrogenase: 
1.~5  m#moles  NAD  +  reduced/rain/rag  protein;  DT 
diaphorase:  1.96 (NAD)  and  ~.14 (NADP)  m#moles 
DCPIP redueed/min/mg protein; Oxidative demethyl- 
ation:  5.33  m#moles  formaldehyde/min/mg  protein. 
All points  represent  the average of four or more ani- 
mals.  Phenobarbital  was  injected once daily. 
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Rates  of  oxidation  of  pyruvate-malate 
(O) and sueeinate (suce.)  ([2]) in the presence of phos- 
phate  and  phosphate  acceptor  catalyzed  by  mito- 
chondria from control and phenobarbital-treated rats. 
Values are expressed as per cent of control values which 
were  0.045 tz atoms  O2/min/mg protein for pymvate- 
malate  and  0.115  #atoms  O2/min/mg  protein  for 
succinate. Each point is the average of four separate 
animals.  Phenobarbital  was  injected  once  daily. 
Results  obtained  with  mitochondrial  oxidative 
enzymes  are  shown  in  Fig.  3.  An  increment in 
mitochondrial  oxidative  utilization  of  succinate 
and pyruvate-malate occurred.  As will be noted, 
both the magnitude and time course of the incre- 
ment  are  comparable  to  those  in  the  curve  ob- 
tained  with  glucuronyl  transferase.  Respiratory 
control  was  as  good  in mitochondria from  drug- 
treated rats as from controls, and P:O ratios were 
also unchanged (Fig. 4). 
In connection with this phenomenon, the results 
of Lee,  Takemori,  and Lardy  (l 1),  on  the incre- 
ments of alpha glycerophosphate oxidation by rat 
liver mitochondria after  treatment of the animals 
with  thyroid  hormone,  were  of interest.  Experi- 
ments were carried out to see whether treatment of 
animals with phenobarbital would lead  to  an in- 
crease in utilization of alpha glycerophosphate  as 
substrate,  as  was  the  case  with  succinate  and 
pyruvate-malate. Oxidation of alpha  glycerophos- 
phate by rat liver mitochondria in the presence of 
phosphate and ADP was measured with the oxygen 
electrode. As will be noted in Fig. 4, alpha glycero- 
phosphate was found to be a  substrate of negligible 
significance  for drug-treated mitochondria, whereas 
in  mitochondria  from  thyroid-treated  animals it 
has been shown to  become almost as good a  sub- 
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FmUnE 4  Oxygen electrode  recording of oxidation of 
succinate  and  alpha  glycerophosphate  (GP)  by  rat 
liver  mitochondria from  animals receiving one  daily 
injection of phenobarbital (phenob.) (80 mg/kg) for  4 
days. Result with control mitochondria (succinate only) 
is also shown. 
strate  as  succinate  (the  response  to  which  is also 
seen in Fig. 4). The same result was obtained twice 
with animals after  1, 2, 3, 4, and 5 days of pheno- 
barbital administration, and in controls. 
Previous work has been done in this laboratory 
to examine the possibility that mitochondria partic- 
ipate in the cellular response  to  administration of 
drugs,  with essentially negative results.  Orrenius, 
Ericsson, and Ernster (12) have shown that, whereas 
treatment  of  rats  with  phenobarbital  causes  a 
greatly enhanced incorporation in vivo of p~2 into 
the microsomal phospholipid, incorporation into the 
phospholipid  of  mitochondria  was  only  slightly 
increased.  However,  the  present  findings  of  in- 
creased  oxidative  utilization  of  succinate  and 
pyruvate-malate  suggests  that  the  extensive met- 
abolic  response  of the liver cell  to  phenobarbital 
also includes alterations in mitochondrial function. 
From the  experiments presented  here using al- 
pha glycerophosphate as substrate, it is quite clear 
that the drug response of the mitochondria is quite 
distinct from the response to thyroid hormone stud- 
ied  by  Lardy  and  his associates, Lee et al.,  (11). 
This indicates that mitochondria, like microsomes, 
are capable of making specific responses to specific 
enhancing substances. 
Since  ethionine blocked  the  response  of alpha 
glycerophosphate  utilization to  thyroid  hormone, 
it was concluded (11)  that the hormone was prob- 
ably not functioning by activating latent enzyme 
but rather via de novo synthesis of enzyme protein. 
Whether the drug-induced enhancement of mito- 
530  n  R  I  ]~  F  N  O  T  E  S chondrial oxidation is due to de novo synthesis is a 
matter of considerable  interest  now  under  study. 
It is of particular  interest  that brain  mitochon- 
dria do not increase their respiration  in hyperthy- 
roidism and do not oxidize alpha  glycerophosphate 
more rapidly  after  administration  of thyroid  sub- 
stance.  In connection  with  this,  it should  also  be 
noted  that  drug-metabolizing  enzymes  in  the 
brain do not respond to  administration  of drugs. 
The increase in the activities of drug-hydroxylat- 
ing  enzymes  after  treatment  with  drugs  is  pro- 
nounced  and  rapid.  A  similar  type  of response  is 
observed with UDPG dehydrogenase  although the 
magnitude of the response is smaller. On the other 
hand,  the responses  of both glucuronyl transferase 
and  mitochondrial  oxidative  enzymes  are  char- 
acterized  by  a  2  day  lag  period.  This  raises  the 
possibility that  there are two different types of re- 
sponse by the cell, an immediate one and a slower, 
possibly secondary response. The nature and signif- 
icance  of these differential responses requires fur- 
ther study. 
SUMMARY 
The administration of phenobarbital  to rats results 
in an  elevation of the hepatic levels of UDPG de- 
hydrogenase  and  glucuronyl  transferase.  The  ac- 
tivities of mitochondrial  oxidative enzymes utiliz- 
ing  succinate  and  pyruvate-malate  are  also 
increased.  The time courses for the increase of the 
mitochondrial  enzyme  levels  and  for  that  of 
glucuronyl  transferase  level are  characterized  by 
a  lag period, whereas UDPG dehydrogenase gives 
a  more rapid response resembling that of oxidative 
demethylation. 
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